Supernus Pharmaceuticals (SUPN), Par Pharma Settle Over Generic Trokendi XR ANDA
Tweet Send to a Friend
Supernus Pharmaceuticals (NASDAQ: SUPN) announced that it has entered into a settlement agreement with Par Pharmaceutical Companies, Inc. and Par ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE